Related Experiment Video
Updated: Jul 5, 2025
The Mouse Stroke Unit Protocol with Standardized Neurological Scoring for Translational Mouse Stroke Studies
Published on: February 7, 2025
Minimal Clinically Important Difference of Scales Reported in Stroke Trials: A Review
Biswamohan Mishra1, Pachipala Sudheer1, Ayush Agarwal1
1Department of Neurology, All India Institute of Medical Sciences, New Delhi 110029, India.
Abstract:
There is a growing awareness of the significance of using minimum clinically important differences (MCIDs) in stroke research. An MCID is the smallest change in an outcome measure that is considered clinically meaningful. This review is the first to provide a comprehensive summary of various scales and patient-reported outcome measures (PROMs) used in stroke research and their MCID values reported in the literature, including a concise overview of the concept of and methods for determining MCIDs in stroke research. Despite the controversies and limitations surrounding the estimation of MCIDs, their importance in modern clinical trials cannot be overstated. Anchor-based and distribution-based methods are recommended for estimating MCIDs, with patient self-evaluation being a crucial component in capturing the patient's perspective on their health. A combination of methods can provide a more comprehensive understanding of the clinical relevance of treatment effects, and incorporating the patient's perspective can enhance the care of stroke patients.
Insights
Minimum clinically important differences (MCIDs) are vital for stroke research, representing the smallest clinically meaningful change. This review summarizes MCID values for stroke outcome measures, emphasizing patient perspectives for better trial interpretation and patient care.
Area of Science:
- Neurology
- Clinical Trials
- Rehabilitation Medicine
Background:
- Minimum Clinically Important Differences (MCIDs) are crucial for interpreting the clinical significance of changes in outcome measures within stroke research.
- Understanding MCIDs helps determine if observed treatment effects in clinical trials are meaningful to patients.
- This review addresses the growing need for standardized MCID application in stroke studies.
Purpose of the Study:
- To comprehensively review and summarize various scales and patient-reported outcome measures (PROMs) used in stroke research.
- To present the reported Minimum Clinically Important Difference (MCID) values for these measures.
- To provide an overview of the concept and methods for determining MCIDs in the context of stroke.
Main Methods:
- Systematic literature review of studies reporting MCID values for stroke-related outcome measures.
- Analysis of different methodologies used for MCID estimation, including anchor-based and distribution-based approaches.
- Emphasis on the inclusion of patient self-evaluation in MCID determination.
Main Results:
- A comprehensive summary of MCID values for numerous scales and PROMs utilized in stroke research.
- Identification of recommended methods for estimating MCIDs, highlighting the importance of patient perspective.
- Discussion of the controversies and limitations associated with MCID estimation.
Conclusions:
- Minimum Clinically Important Differences (MCIDs) are indispensable for modern stroke clinical trials.
- A combination of estimation methods, incorporating patient-reported outcomes, provides a robust understanding of clinical relevance.
- Integrating MCIDs and patient perspectives can significantly enhance stroke patient care and treatment evaluation.
